Á¦¸ñ
ÀÛ¼ºÀÚ
À̸ÞÀÏ
ºñ¹Ð¹øÈ£
³»¿ë
The 2010s will also be
±¸Âî
=±¸Âî¿©¼ºÀÇ·ù
remembered for the decade-long saga of Caster Semenya, a story that continues to divide opinion in sport like little else. In 2019, the Court of Arbitration for Sport (Cas) ruled
¸íǰ·¹Çø®Ä«»çÀÌÆ®
=¸íǰ·¹Çø®Ä«»çÀÌÆ®
in favour of a hugely controversial IAAF rule that forced the South African runner - and other athletes with differences in sexual development (DSD) - to take hormone-limiting drugs if she wanted to compete in the middle-distance events she had dominated for years. After a long legal battle, Semenya pulled out of the World Championships. For Semenya's supporters, the eligibility regulation was an appalling breach of human rights and a
³ÃÁ¤¼ö±â·»Å»
=¿õÁøÄÚ¿þÀÌ ³ÃÁ¤¼ö±â·»Å» Á¦ºù±â°â¿ë ½Ç¹ö / CPI-6500LÃÖ°í
discriminatory act of sexism and racism designed to target her. For others, it was a necessary and proportionate step to protect women's sport and fair competition. But whatever one's perspective, there is no doubt that the debate has confronted sport with uncomfortable questions
¿äÁö¾ß¸¶¸ðÅä
=¿äÁö¾ß¸¶¸ðÅä¿©¼ºÀÇ·ù
around gender identity and human biology, the suitability of sport's traditional male and female categories,
È«Äá¸íǰ³²¼º°¡¹æ
=È«Äá¸íǰ³²¼º°¡¹æ È«Äá¸íǰ¿©¼º°¡¹æ È«Äá¸íǰ³²¼ºÁö°©
the reliability of the medical science on which the IAAF's rule relies, perceptions of womanhood and sport's complex relationship with the law.